Solasia Pharma K.K. (TYO:4597)
Japan flag Japan · Delayed Price · Currency is JPY
26.00
+2.00 (8.33%)
May 29, 2026, 3:30 PM JST

Solasia Pharma K.K. Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-890-876-1,961-1,135-2,492-2,442
Depreciation & Amortization
3737195500534495
Loss (Gain) From Sale of Assets
--959-431-
Loss (Gain) on Equity Investments
21453-
Other Operating Activities
92-6-36-12-2
Change in Accounts Receivable
-14-142-164540-44651
Change in Inventory
-1715-5-108-144
Change in Accounts Payable
-263108-92-118-65-626
Change in Other Net Operating Assets
15837-7-1347
Operating Cash Flow
-1,121-847-1,033-359-2,074-2,473
Capital Expenditures
---1---2
Cash Acquisitions
-----14-
Sale (Purchase) of Intangibles
-----403-161
Investment in Securities
-94-77----
Other Investing Activities
-3-41--1-1
Investing Cash Flow
-97-81---418-164
Long-Term Debt Issued
--500-500-
Long-Term Debt Repaid
---500--500-1,000
Net Debt Issued (Repaid)
8-----1,000
Issuance of Common Stock
1,7181,4581,2153182,6211,403
Other Financing Activities
-42-33-35-43-50-42
Financing Cash Flow
1,6841,4251,1802752,571361
Foreign Exchange Rate Adjustments
3951171025
Miscellaneous Cash Flow Adjustments
-4-2-11-11
Net Cash Flow
501500157-7688-2,250
Free Cash Flow
-1,121-847-1,034-359-2,074-2,475
Free Cash Flow Margin
-273.42%-197.44%-327.21%-58.18%-189.93%-442.75%
Free Cash Flow Per Share
-4.48-3.57-5.20-2.13-13.65-19.02
Cash Interest Paid
111-11
Cash Income Tax Paid
--1252822
Levered Free Cash Flow
--518.63-1,25262.13-1,949-1,667
Unlevered Free Cash Flow
-740.5-509.88-1,24962.13-1,937-1,653
Change in Working Capital
-279-11-224307-538-524